Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Implementation of new techniques in the management of upper gastrointestinal bleeding

View through CrossRef
Background: In recent years, many endoscopic hemostasis techniques helped to improve the prognosis of upper gastrointestinal bleeding. It includes: esophageal band ligation and Histoacryl injection in variceal upper GI bleeding; dilute adrenalin injection, hemoclipping, argon plasma coagulation and Hemospray in non-variceal upper GI bleeding. But domestic studies about these techniques’ efficacy are limited. Objectives: 1. To describe characteristics of patients and endoscopic lesions in upper GI bleeding. 2. To assess the efficacy of some endoscopic hemostasis techniques in upper GI bleeding. Subject and methods: Interventional study concluded 346 upper GI bleeding patients, 365 therapeutic upper endoscopy to get hemostasis in Gastroenterology - Endoscopy Center, Hue University of Medicine and Pharmacy Hospital from 11/2017 to 4/2022. Result: Mean age of patients is 55.6 ± 17.9, minimum is 9, maximum is 95. Male/female ratio is 2.5. The causes of bleeding: esophageal varices 35.5%, gastric varices 4.3%, peptic ulcer diseases 50.9%, esophago-gastric junction tear 5.5%, angiodysplasia 2.6%, and others 1.2%. Hemostatic techniques: esophageal band ligation 33.7%, Histoacryl injection 4.1%, hemoclipping 52.6%, dilute adrenalin injection 15.9%, APC 7.9%, Hemospray 0.8% and others 0.3%. Successful rate of initiating endoscopic hemostasis is high (100%), permanent hemostasis is high (99.1%); recurrent bleeding rate is low (2.3%), endoscopic hemostasis failure is low (0.9%); operation rate is low (0.9%). Conclusion: Endoscopic hemostasis techniques showed good safety and efficacy, failure and operation rate are very low. Using new techniques in case of failure of traditional techniques was beneficial and safe Key words: upper gastrointestinal bleeding, endoscopy
Title: Implementation of new techniques in the management of upper gastrointestinal bleeding
Description:
Background: In recent years, many endoscopic hemostasis techniques helped to improve the prognosis of upper gastrointestinal bleeding.
It includes: esophageal band ligation and Histoacryl injection in variceal upper GI bleeding; dilute adrenalin injection, hemoclipping, argon plasma coagulation and Hemospray in non-variceal upper GI bleeding.
But domestic studies about these techniques’ efficacy are limited.
Objectives: 1.
To describe characteristics of patients and endoscopic lesions in upper GI bleeding.
2.
To assess the efficacy of some endoscopic hemostasis techniques in upper GI bleeding.
Subject and methods: Interventional study concluded 346 upper GI bleeding patients, 365 therapeutic upper endoscopy to get hemostasis in Gastroenterology - Endoscopy Center, Hue University of Medicine and Pharmacy Hospital from 11/2017 to 4/2022.
Result: Mean age of patients is 55.
6 ± 17.
9, minimum is 9, maximum is 95.
Male/female ratio is 2.
5.
The causes of bleeding: esophageal varices 35.
5%, gastric varices 4.
3%, peptic ulcer diseases 50.
9%, esophago-gastric junction tear 5.
5%, angiodysplasia 2.
6%, and others 1.
2%.
Hemostatic techniques: esophageal band ligation 33.
7%, Histoacryl injection 4.
1%, hemoclipping 52.
6%, dilute adrenalin injection 15.
9%, APC 7.
9%, Hemospray 0.
8% and others 0.
3%.
Successful rate of initiating endoscopic hemostasis is high (100%), permanent hemostasis is high (99.
1%); recurrent bleeding rate is low (2.
3%), endoscopic hemostasis failure is low (0.
9%); operation rate is low (0.
9%).
Conclusion: Endoscopic hemostasis techniques showed good safety and efficacy, failure and operation rate are very low.
Using new techniques in case of failure of traditional techniques was beneficial and safe Key words: upper gastrointestinal bleeding, endoscopy.

Related Results

Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Introduction Despite prophylactic platelet transfusions, World Health Organization (WHO) grade ≥ 2 bleeding occurs in 50 to 70% of patients with hematologic malignan...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
ETIOLOGY OF GASTROINTESTINAL BLEEDING IN CHILDREN
ETIOLOGY OF GASTROINTESTINAL BLEEDING IN CHILDREN
Objectives. Identification of clinical, endoscopic, etiological characteristic of children diagnosed with upper and lower gastrointestinal bleeding. Material and methods. It was co...
Bleeding Disorder Referrals to Hematology Clinic: A Single Institution Experience
Bleeding Disorder Referrals to Hematology Clinic: A Single Institution Experience
BACKGROUND Our tertiary care pediatric hematology/oncology/BMT service receives hundreds of referrals yearly for bleeding disorder evaluation both due to bleeding sy...
Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study
Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study
Introduction: Acquired hemophilia A (AHA) is an autoimmune disorder marked by the development of autoantibodies targeting coagulation factor VIII. This rare condi...
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Background: Despite optimal prophylactic platelet (plt) transfusion therapy for severe thrombocytopenia in patients undergoing treatment for hematologic malignancy, WHO Grade 2 or ...
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A‐TREAT clinical trial
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A‐TREAT clinical trial
AbstractBackgroundDespite prophylactic platelet transfusions, hypoproliferative thrombocytopenia is associated with bleeding; historical risk factors include hematocrit (HCT) 25%, ...

Back to Top